by Pill Pals Customer Service | Mar 12, 2025 | News
This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by date of approval in reverse chronological order.Trade Name/Proper...
by Pill Pals Customer Service | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: National Institute of Allergy and Infectious Diseases, Hamilton, Montana,...
by Pill Pals Customer Service | Mar 12, 2025 | News
FDA considers advancing the availability of evidence-based guidelines for opioid analgesics and other medications with abuse potential a high-impact opportunity to support the safe use of these products. In alignment with the FDA Overdose Prevention Framework priority...
by Pill Pals Customer Service | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.K....
by Pill Pals Customer Service | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Virology Department, AP-HP, Hôpital Saint-Louis, Paris, France (M....
by Pill Pals Customer Service | Mar 12, 2025 | News
ListenWelcome to the FDA Drug Safety Podcast for health care professionals from the Division of Drug Information.Based on its review of postmarket clinical trial data, on December 12, 2024, the FDA announced identified cases of serious liver injury among patients...
by Pill Pals Customer Service | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Institut Pasteur, Paris, France (C. Savin, J. Pizarro-Cerdá); Instituto...
by Pill Pals Customer Service | Mar 12, 2025 | News
Update | February 7, 2025The Drug Development Tool (DDT) Qualification Programs and ISTAND1 Pilot Program, have updated the program metrics to give the public and industry partners more clarity and transparency around our activities. In accordance with the 21st...
by Pill Pals Customer Service | Mar 12, 2025 | News
Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Seunghyun Cho Recipient Title General Manager Natuzen Co., Ltd. 289 Namdongdong-RoNamdong-guIncheon21639South Korea Issuing Office: Center for Drug Evaluation and Research | CDER United States...
Bupropion 150 mg Extended-Release (XL)Tablets
$20.97
Docusate Sodium /Senna 8.6-50 mg Tablets 100 Count --- Generic for Peri-Colace --- Rugby Pharma
Original price was: $9.99.$7.99Current price is: $7.99.
Iron Sphere Pendant Lighting
Original price was: $95.99.$88.99Current price is: $88.99.
E27 Modern Double Wall Light
Price range: $71.99 through $79.99
Tall Cat Scratching Post
Price range: $19.99 through $21.99
Turtle Shaped Flower Pot
$8.99
Nylon Sports Bra for Women
Price range: $5.99 through $10.99